| 1 |
33829270 | A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R. | 2021 May 28 |
2 |
| 2 |
34498213 | Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation. | 2021 Sep |
1 |
| 3 |
31758670 | Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation. | 2020 Jan |
10 |
| 4 |
31941753 | IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer. | 2020 Apr |
4 |
| 5 |
32929081 | Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer. | 2020 Sep 14 |
2 |